Table 2 Infection prevalence and MOI in subjects stratified by blood groups and haemoglobinopathies before and after the transmission season

193 (52)

81/193 (42)

2.6 (1 – 7)

99/193 (51)

4.1 (1–10)^g***

100 (27)

47/100 (47)

2.6 (1 – 7)

50/100 (50)

4.0 (1 – 9)^g**

69 (18)

34/69 (49)

2.3 (1 – 6)

32/69 (46)

4.2 (1 – 10)^g*

10 (3)

2/10 (20)

4.0 (1 – 7)

7/10 (70)

4.6 (2 – 8)^g*

319 (86)

144/319 (45)

2.5 (1 – 7)

162/319 (51)

4.0 (1–10)^g***

51 (14)

19/51 (37)

2.7 (1 – 5)

26/51 (51)

4.5 (1 – 10)^g**

234 (76)

103/234 (44)

2.3 (1 – 7)

118/234 (50)

3.9 (1–10)^g***

75 (24)

37/75 (49)

2.8 (1 – 7)

36/75 (48)

4.1 (1 – 9)

141 (81)

60/141 (43)

2.7 (1 – 7)

73/141 (52)^f

4.4 (1 – 10)^g**

34 (19)

11/34 (32)

2.7 (1 – 4)

9/34 (26)

4.6 (1 – 10)

166 (87)

77/166 (46)

2.5 (1 – 7)

90/166 (54)

3.8 (1–10)^g***

24 (13)

14/24 (58)

1.7 (1 – 4)

14/24 (58)

3.4 (1 – 7)